லோன் டெஸ்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லோன் டெஸ்ட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லோன் டெஸ்ட் Today - Breaking & Trending Today

Destiny Pharma inks agreement with US health institutes to evaluate XF-73 drug | 15 March 2021


15 March 2021 | 09:49am
StockMarketWire.com - Biotechnology company Destiny Pharma said it had entered into an agreement under which the US government s National Institute of Allergy and Infectious Diseases would evaluate the formulation of the company s drug to prevent postsurgical staphylococcal infections.
Destiny Pharma would utilize preclinical National Institute of Allergy and Infectious Diseases services programme to complete the preclinical safety studies that would support the planned clinical development in serious wound infections.
Destiny Pharma will provide the XF-73 formulation to be tested in these preclinical studies and the project was planned to complete in 2022.
At 9:49am: [LON:DEST] Destiny Pharma Plc share price was 0p at 68.5p ....

National Institute Of Allergy , Destiny Pharma Plc , Destiny Pharma , National Institute , Infectious Diseases , Lon Dest , Dest L , தேசிய நிறுவனம் ஆஃப் ஒவ்வாமை , விதி பார்மா ப்ல் , விதி பார்மா , தேசிய நிறுவனம் , தொற்று நோய்கள் , லோன் டெஸ்ட் , டெஸ்ட் ல் ,

Director Deals - Destiny Pharma PLC (DEST) | 8 January 2021


Director Deals
8 January 2021 | 06:03am
StockMarketWire.com - Philip Rodgers, Chairman, bought 9,000 shares in the company on the 6th January 2021 at a price of £0.88. The Director now holds 47,462 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Latest share price and company details: ....

Philip Rodgers , Destiny Pharma Plc , Lon Dest , Dest L , பிலிப் ரோட்ஜர்ஸ் , விதி பார்மா ப்ல் , லோன் டெஸ்ட் , டெஸ்ட் ல் ,